Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03026127
Other study ID # 1603017115
Secondary ID 5R33MH1105421R61
Status Recruiting
Phase N/A
First received
Last updated
Start date March 28, 2017
Est. completion date August 2024

Study information

Verified date October 2023
Source Weill Medical College of Cornell University
Contact Dimitris Kiosses, PhD
Phone 9149974381
Email dkiosses@med.cornell.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this trial is to refine and test a novel emotion-regulation based psychosocial intervention designed to reduce suicide risk in middle-aged and older adults (50-90 years old) who have been discharged after a suicide-related hospitalization (i.e. for suicidal ideation or suicide attempt).


Description:

The Investigators developed a novel psychosocial intervention called "Cognitive Reappraisal Intervention for Suicide Prevention (CRISP)," which aims to improve cognitive reappraisal ability (i.e. the ability to modify the appraisal of a situation to alter its emotional significance) (target), and reduce suicide risk (outcome). The conceptual framework views suicidal ideation and behavior as failed attempts to regulate negative emotions and by improving cognitive reappraisal, an effective emotion regulation strategy, the investigators expect to reduce suicide risk. This theory is supported by studies showing that unsuccessful attempts to regulate negative emotions and decreased cognitive reappraisal are associated with increased suicidal ideation and behavior. The R61 phase is a proof-of-principle phase and its goals are to optimize CRISP and test its engagement with cognitive reappraisal. Certified social workers will administer 12 weekly sessions of CRISP to 40 middle-aged and older adults (50-90 years old) after a suicide-related hospitalization. Research assistants, unaware of the study aims, will conduct assessments at study entry (hospital admission), discharge, 6 and 12 weeks post-discharge. Target engagement will be assessed with EEG assessments during a standard pictured-based stimuli and our novel cognitive reappraisal paradigm. The R33 phase aims to provide further evidence of target engagement of the optimized CRISP in a larger sample, evaluate the relationship of cognitive reappraisal with suicide risk as measured with Columbia Suicide Severity Rating Scale (C-SSRS) and estimate implementation parameters for a large-scale clinical trial. A different sample of 90 middle-aged and older adults (using the same inclusion/exclusion criteria as for the R61 phase) will be randomized to CRISP or to Supportive Therapy (ST, a control treatment not designed to improve emotion regulation). Assessments will be conducted on admission, at discharge, and at 6, 12 and 24 weeks post-discharge. Primary aims are: 1) CRISP participants will show improvement in cognitive reappraisal ability from discharge to end of treatment; and 2) improvement in cognitive reappraisal ability will be associated with suicide risk over 24 weeks.


Recruitment information / eligibility

Status Recruiting
Enrollment 90
Est. completion date August 2024
Est. primary completion date August 2024
Accepts healthy volunteers No
Gender All
Age group 50 Years to 90 Years
Eligibility Inclusion Criteria: - 50 years and older - Diagnosis (based on SCID-5 Clinical Trials Version to assess DSM-5 diagnoses): Any DSM-5 depression or anxiety diagnosis, including major depressive disorder, bipolar depression, depressive disorder Not Elsewhere Classified, anxiety disorder Not Elsewhere Classified, adjustment disorder with anxiety and depressed mood (but without any of the diagnoses shown under Exclusion Criteria) - Recent hospitalization for suicidal ideation or suicide attempt. At hospital admission, Columbia Suicide Severity Rating Scale greater or equal to 3, "Active Suicidal Ideation with any methods or a suicide attempt." - Patients with any degree of suicidal ideation at discharge (Columbia Suicide Severity Rating greater or equal to 0) will be included. - Patients who are on psychotropics and on after-care community psychotherapy will also be included. Exclusion Criteria: - History or current diagnosis of Psychotic Disorders; Current Diagnosis of Bipolar I or Bipolar II, with current episode hypomanic, manic or mixed; Diagnosis of Dementia. - Cognitive Impairment: Mini Mental State Exam (MMSE) < 24. - Acute or severe medical illness (i.e. delirium; decompensated cardiac, liver, or kidney failure; major surgery; stroke or myocardial infarction during the three months prior to entry. - Aphasia, sensory problems, and/or inability to speak English.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Cognitive Reappraisal Intervention for Suicide Prevention
Cognitive Reappraisal Intervention for Suicide Prevention, or CRISP, is a psychosocial intervention aimed to reduce suicide risk in middle-aged and older adults who have been hospitalized for suicidal ideation or suicide attempt. CRISP offers a combination of emotion regulation techniques, including changing the subject's perspective or the way he/she thinks to improve emotion reactions. Additional strategies taught include the provision of environmental adaptation tools (notes, checklists, calendars, etc), phone calls, and a tablet application called WellPATH.
Supportive Therapy
ST focuses on: 1. facilitating expression of affect; 2. conveying to the patient that he or she is understood; 3. offering empathy; and 4. highlighting positive experiences. The ST manual aims to standardize nonspecific therapeutic factors

Locations

Country Name City State
United States Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medicine White Plains New York

Sponsors (5)

Lead Sponsor Collaborator
Weill Medical College of Cornell University Florida State University, National Institute of Mental Health (NIMH), Rutgers University, Stanford University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Change in Suicide Severity, as measured by the Columbia Suicide Severity Rating Scale (CSSR-S) The CSSR-S assesses risk for suicide, specifically severity of thoughts, intensity of thoughts, behavior and lethality. Questions are scored in categories, 1-10, with lower numbers indicating less severity and higher numbers more severity. Baseline, Weeks 1-24
Primary Emotion Regulation, as measured by the Electroencephalogram (EEG), Autobiographical Affective Regulation Task (AART), and a standard picture-based emotion regulation task. A composite measure of the above tasks with the EEG will be analyzed to assess the patient's cognitive reappraisal ability. Baseline, 6, 12, and 24 weeks
See also
  Status Clinical Trial Phase
Completed NCT01118169 - Personal Values, Interpersonal Needs, and Suicidal Ideation in a Veteran Population N/A
Completed NCT02877316 - MYPLAN - Effectiveness of a Safety Plan App to Manage Crisis of Persons at Risk of Suicide N/A
Completed NCT06130943 - Evaluation of the Quality of Telephone Calls to a Suicide Prevention Helpline
Recruiting NCT06139887 - Suicide Prevention Program for Veterans Discharged From Community Care Settings N/A
Recruiting NCT05067686 - Health Professionals Perspective on Suicide
Not yet recruiting NCT06378541 - Smartphone App Enhanced Facilitation Among Veterans in a Mental Health Inpatient Setting (Project HOPE) N/A
Recruiting NCT05994612 - Suicide Prevention for Substance Using Youth Experiencing Homelessness N/A
Recruiting NCT06164106 - Feasibility Trial of a Single Session of Crisis Response Planning for Youth at High Risk for Suicide N/A
Recruiting NCT06094959 - Integrating Suicide Prevention Packages Into Task-shifted Mental Health Interventions in Low-resourced Contexts N/A
Completed NCT06282263 - The Effect of the Awareness Development Program on Suicide Prevention for Oncology Nurses N/A
Completed NCT00516932 - Pharmacogenomics of Antidepressant Response in Children and Adolescents N/A
Recruiting NCT06208293 - Suicide Prevention Integration Into Task-shifted Mental Health Interventions N/A
Completed NCT03114917 - Cognitive AppRoaches to coMbatting Suicidality N/A
Recruiting NCT04446468 - Suicide Prevention Study of VA-BIC in the Veteran Population N/A
Recruiting NCT03136094 - Suicide in Urban Natives: Detection and Networks to Combat Events N/A
Completed NCT02996344 - Suicide Prevention Training for PC Providers-in-training N/A
Completed NCT04565951 - Increasing Help-Seeking Behavior Among Transitioning Veterans at Risk for Suicide With Online Gatekeeper Training N/A
Not yet recruiting NCT06465381 - Safety Planning and Cognitive Behavioral Therapy for Adolescent Suicide Prevention in Mozambique N/A
Recruiting NCT05995678 - A Mixed Methods Pilot Trial of the STEP Home Workshop to Improve Reintegration and Reduce Suicide Risk for Recently Transitioned Veterans N/A
Recruiting NCT06225661 - Focused Suicide Prevention Strategy for Youth Presenting to the Emergency Department With Suicide Related Behaviour N/A